Bearish flow noted in GSK (GSK) Pharma with 6,103 puts trading, or 5x expected. Most active are 3/14 weekly 39.5 puts and Mar-25 41.5 calls, with total volume in those strikes near 5,500 contracts. The Put/Call Ratio is 1.56, while ATM IV is up over 2 points on the day. Earnings are expected on April 30th.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GSK:
- Trevi Therapeutics upgraded to Strong Buy from Outperform at Raymond James
- GSK Pharma put volume heavy and directionally bearish
- GSK announces U.S. FDA accepted for review BLA for depemokimab
- Zymeworks achieves $14M milestone from GSK
- Eine-Leaver: Unilever Stock Stumbles as CEO Hein Schumacher Departs in Surprise Move